Trade Summary

4 days ago, Coloma Jason V, serving as Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 27,858 shares at $26.04 per share, for a total transaction value of $725,494.63. Following this transaction, Coloma Jason V now holds 319,079 shares of MAZE.

This sale represents a 8.03% decrease in Coloma Jason V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:14 PM ET, 2 days after the trade was made.

Maze Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.